TY - JOUR AU - Zhu, N. AU - Zhang, D. AU - Wang, W. PY - 2020 DA - 2020// TI - A novel coronavirus from patients with pneumonia in China, 2019 JO - N Engl J Med VL - 382 UR - https://doi.org/10.1056/NEJMoa2001017 DO - 10.1056/NEJMoa2001017 ID - Zhu2020 ER - TY - JOUR AU - Huang, C. AU - Wang, Y. AU - Li, X. PY - 2020 DA - 2020// TI - Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China JO - Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30183-5 DO - 10.1016/S0140-6736(20)30183-5 ID - Huang2020 ER - TY - JOUR AU - Chen, N. AU - Zhou, M. AU - Dong, X. PY - 2020 DA - 2020// TI - Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study JO - Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30211-7 DO - 10.1016/S0140-6736(20)30211-7 ID - Chen2020 ER - TY - JOUR AU - Wang, D. a. w. e. i. AU - Hu, B. o. AU - Hu, C. h. a. n. g. AU - Zhu, F. a. n. g. f. a. n. g. AU - Liu, X. i. n. g. AU - Zhang, J. i. n. g. AU - Wang, B. i. n. b. i. n. AU - Xiang, H. u. i. AU - Cheng, Z. h. e. n. s. h. u. n. AU - Xiong, Y. o. n. g. AU - Zhao, Y. a. n. AU - Li, Y. i. r. o. n. g. AU - Wang, X. i. n. g. h. u. a. n. AU - Peng, Z. h. i. y. o. n. g. PY - 2020 DA - 2020// TI - Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China JO - JAMA VL - 323 UR - https://doi.org/10.1001/jama.2020.1585 DO - 10.1001/jama.2020.1585 ID - Wang2020 ER - TY - JOUR AU - Lo, M. K. AU - Jordan, R. AU - Arvey, A. PY - 2017 DA - 2017// TI - GS-5734 and its parent nucleoside analog inhibit filo-, pneumo-, and paramyxoviruses JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/srep43395 DO - 10.1038/srep43395 ID - Lo2017 ER - TY - BOOK PY - 2020 DA - 2020// TI - WHO R&D blueprint: informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection PB - WHO CY - Geneva ID - ref6 ER - TY - JOUR AU - Warren, T. K. AU - Jordan, R. AU - Lo, M. K. PY - 2016 DA - 2016// TI - Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys JO - Nature VL - 531 UR - https://doi.org/10.1038/nature17180 DO - 10.1038/nature17180 ID - Warren2016 ER - TY - JOUR AU - Jordan, P. C. AU - Liu, C. AU - Raynaud, P. PY - 2018 DA - 2018// TI - Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase JO - PLoS Pathog VL - 14 UR - https://doi.org/10.1371/journal.ppat.1006889 DO - 10.1371/journal.ppat.1006889 ID - Jordan2018 ER - TY - JOUR AU - Tchesnokov, E. P. AU - Feng, J. Y. AU - Porter, D. P. AU - Gotte, M. PY - 2019 DA - 2019// TI - Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir JO - Viruses VL - 11 UR - https://doi.org/10.3390/v11040326 DO - 10.3390/v11040326 ID - Tchesnokov2019 ER - TY - JOUR AU - Sheahan, T. P. AU - Sims, A. C. AU - Graham, R. L. PY - 2017 DA - 2017// TI - Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses JO - Sci Transl Med VL - 9 UR - https://doi.org/10.1126/scitranslmed.aal3653 DO - 10.1126/scitranslmed.aal3653 ID - Sheahan2017 ER - TY - JOUR AU - Wang, M. AU - Cao, R. AU - Zhang, L. PY - 2020 DA - 2020// TI - Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro JO - Cell Res VL - 30 UR - https://doi.org/10.1038/s41422-020-0282-0 DO - 10.1038/s41422-020-0282-0 ID - Wang2020 ER - TY - JOUR AU - Brown, A. J. AU - Won, J. J. AU - Graham, R. L. PY - 2019 DA - 2019// TI - Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase JO - Antivir Res VL - 169 UR - https://doi.org/10.1016/j.antiviral.2019.104541 DO - 10.1016/j.antiviral.2019.104541 ID - Brown2019 ER - TY - JOUR AU - Wit, E. AU - Feldmann, F. AU - Cronina, J. PY - 2020 DA - 2020// TI - Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection JO - Proc Natl Acad Sci U S A VL - 117 UR - https://doi.org/10.1073/pnas.1922083117 DO - 10.1073/pnas.1922083117 ID - Wit2020 ER - TY - JOUR AU - Sheahan, T. P. AU - Sims, A. C. AU - Leist, S. R. PY - 2020 DA - 2020// TI - Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV JO - Nat Commun VL - 11 UR - https://doi.org/10.1038/s41467-019-13940-6 DO - 10.1038/s41467-019-13940-6 ID - Sheahan2020 ER - TY - JOUR AU - Mulangu, S. AU - Dodd, L. E. AU - Davey, R. T. PY - 2019 DA - 2019// TI - A randomized, controlled trial of Ebola virus disease therapeutics JO - N Engl J Med VL - 381 UR - https://doi.org/10.1056/NEJMoa1910993 DO - 10.1056/NEJMoa1910993 ID - Mulangu2019 ER - TY - JOUR AU - Whitehead, J. AU - Stratton, I. PY - 1983 DA - 1983// TI - Group sequential clinical trials with triangular continuation regions JO - Biometrics VL - 39 UR - https://doi.org/10.2307/2530822 DO - 10.2307/2530822 ID - Whitehead1983 ER - TY - JOUR AU - Schulz, K. F. AU - Altman, D. G. AU - Moher, D. PY - 2010 DA - 2010// TI - CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials JO - J Pharmacol Pharmacother VL - 1 UR - https://doi.org/10.4103/0976-500X.72352 DO - 10.4103/0976-500X.72352 ID - Schulz2010 ER - TY - JOUR AU - Dimairo, M. AU - Coates, E. AU - Pallmann, P. PY - 2018 DA - 2018// TI - Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design JO - BMC Med VL - 16 UR - https://doi.org/10.1186/s12916-018-1196-2 DO - 10.1186/s12916-018-1196-2 ID - Dimairo2018 ER - TY - BOOK AU - Whitehead, J. PY - 1997 DA - 1997// TI - The design and analysis of sequential clinical trials PB - Wiley CY - Chichester ID - Whitehead1997 ER - TY - BOOK PY - 2015 DA - 2015// TI - Ethics in epidemics, emergencies and disasters: research, surveillance and patient care ID - ref20 ER - TY - JOUR AU - Saxena, A. AU - Horby, P. AU - Amuasi, J. PY - 2019 DA - 2019// TI - Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel JO - BMC Med Ethics VL - 20 UR - https://doi.org/10.1186/s12910-019-0366-x DO - 10.1186/s12910-019-0366-x ID - Saxena2019 ER - TY - BOOK PY - 2020 DA - 2020// TI - Research in global health emergencies: ethical issues ID - ref22 ER - TY - BOOK PY - 2011 DA - 2011// TI - Guidance for Industry. Influenza: developing drugs for treatment and/or prophylaxis ID - ref23 ER -